Polaryx Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on XNAS, led by CEO Alex Yang, with a market cap of $161.4M.
Based on Q4 2025 filing
Common questions about Polaryx Therapeutics, Inc.
Polaryx Therapeutics, Inc. (PLYX) has a market capitalization of $161.4M and trades on XNAS.